Deshane J - Search Results

1

Neoplastic reversion accomplished by high efficiency adenoviral-mediated delivery of an anti-ras ribozyme.

Feng M, Cabrera G, Deshane J, Scanlon KJ, Curiel DT. Feng M, et al. Among authors: deshane j. Cancer Res. 1995 May 15;55(10):2024-8. Cancer Res. 1995. PMID: 7743496

2

Local SARS-CoV-2 Peptide-Specific Immune Responses in Lungs of Convalescent and Uninfected Human Subjects.

Goliwas KF, Wood AM, Simmons CS, Khan R, Khan SA, Wang Y, Berry JL, Athar M, Mobley JA, Kim YI, Thannickal VJ, Harrod KS, Donahue JM, Deshane JS. Goliwas KF, et al. Among authors: deshane js. medRxiv [Preprint]. 2022 Jan 21:2021.09.02.21263042. doi: 10.1101/2021.09.02.21263042. medRxiv. 2022. PMID: 34518842 Free PMC article. Preprint.

3

NK and NKT cells in the pathogenesis of Hidradenitis suppurativa: Novel therapeutic strategy through targeting of CD2.

Kashyap MP, Mishra B, Sinha R, Jin L, Kumar N, Goliwas KF, Deshane J, Elewski BE, Elmets CA, Athar M, Shahid Mukhtar M, Raman C. Kashyap MP, et al. Among authors: deshane j. bioRxiv [Preprint]. 2023 Nov 2:2023.10.31.565057. doi: 10.1101/2023.10.31.565057. bioRxiv. 2023. PMID: 37961206 Free PMC article. Preprint.

4

Targeted eradication of ovarian cancer mediated by intracellular expression of anti-erbB-2 single-chain antibody.

Deshane J, Cabrera G, Grim JE, Siegal GP, Pike J, Alvarez RD, Curiel DT. Deshane J, et al. Gynecol Oncol. 1995 Oct;59(1):8-14. doi: 10.1006/gyno.1995.1260. Gynecol Oncol. 1995. PMID: 7557620

5

Intracellular single-chain antibody directed against erbB2 down-regulates cell surface erbB2 and exhibits a selective anti-proliferative effect in erbB2 overexpressing cancer cell lines.

Deshane J, Loechel F, Conry RM, Siegal GP, King CR, Curiel DT. Deshane J, et al. Gene Ther. 1994 Sep;1(5):332-7. Gene Ther. 1994. PMID: 7584099

6

Targeted tumor killing via an intracellular antibody against erbB-2.

Deshane J, Siegal GP, Alvarez RD, Wang MH, Feng M, Cabrera G, Liu T, Kay M, Curiel DT. Deshane J, et al. J Clin Invest. 1995 Dec;96(6):2980-9. doi: 10.1172/JCI118370. J Clin Invest. 1995. PMID: 8675670 Free PMC article.

7

Intracellular antibody against erbB-2 mediates targeted tumor cell eradication by apoptosis.

Deshane J, Grim J, Loechel S, Siegal GP, Alvarez RD, Curiel DT. Deshane J, et al. Cancer Gene Ther. 1996 Mar-Apr;3(2):89-98. Cancer Gene Ther. 1996. PMID: 8729907

8

erbB-2 knockout employing an intracellular single-chain antibody (sFv) accomplishes specific toxicity in erbB-2-expressing lung cancer cells.

Grim J, Deshane J, Feng M, Lieber A, Kay M, Curiel DT. Grim J, et al. Among authors: deshane j. Am J Respir Cell Mol Biol. 1996 Sep;15(3):348-54. doi: 10.1165/ajrcmb.15.3.8810638. Am J Respir Cell Mol Biol. 1996. PMID: 8810638

9

Gene therapy and ovarian cancer: a review.

Barnes MN, Deshane JS, Rosenfeld M, Siegal GP, Curiel DT, Alvarez RD. Barnes MN, et al. Among authors: deshane js. Obstet Gynecol. 1997 Jan;89(1):145-55. doi: 10.1016/s0029-7844(96)00296-7. Obstet Gynecol. 1997. PMID: 8990458 Review.

10

A novel gene therapy strategy for elimination of prostate carcinoma cells from human bone marrow.

Kim M, Wright M, Deshane J, Accavitti MA, Tilden A, Saleh M, Vaughan WP, Carabasi MH, Rogers MD, Hockett RD Jr, Grizzle WE, Curiel DT. Kim M, et al. Among authors: deshane j. Hum Gene Ther. 1997 Jan 20;8(2):157-70. doi: 10.1089/hum.1997.8.2-157. Hum Gene Ther. 1997. PMID: 9017419

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

110 results

Search Page

Filters